Skip to main content
Year archive

OXFORD NANOPORE TECHNOLOGIES PLC — 2022 filings

All 66 regulatory filings released by OXFORD NANOPORE TECHNOLOGIES PLC (ONT) in 2022, sourced directly from the official regulator.

66 Filings
2022 Period
2022 filings (66)
Filing Released Lang
Holding(s) in Company
Major Shareholding Notification
2022-12-28 English
Holding(s) in Company
Major Shareholding Notification
2022-12-23 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-12-13 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-12-01 English
Director/PDMR Shareholding
Director's Dealing
2022-11-11 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-11-11 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-11-01 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-10-11 English
Director/PDMR Shareholding
Director's Dealing
2022-10-10 English
Block listing Interim Review
Net Asset Value
2022-10-06 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2022-10-03 English
Director/PDMR Shareholding
Director's Dealing
2022-09-29 English
Director/PDMR Shareholding
Director's Dealing
2022-09-14 English
Share Incentive Plan - Director/PDMR Shareholding
Remuneration Information
2022-09-13 English
Interim results for the period ended 30 June 2022
Interim / Quarterly Report H1 2022
2022-09-13 English
Oxford Nanopore to present at upcoming conferences
Report Publication Announcement
2022-09-12 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-09-01 English
Notice of Results
Report Publication Announcement
2022-08-24 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-08-11 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2022-08-01 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-07-12 English
Sale and leaseback of headquarters building
Capital/Financing Update
2022-07-11 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2022-07-01 English
Duncan Tatton-Brown appointed as Non-Exec Chair
Board/Management Information
2022-06-30 English
Result of 2022 AGM
Declaration of Voting Results & Voting Rights Announcements
2022-06-23 English
Result of AGM
AGM Information
2022-06-23 English
Share Incentive Plan - Director/PDMR Shareholding
Remuneration Information
2022-06-13 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2022-06-01 English
Director/PDMR Shareholding
Director's Dealing
2022-05-31 English
ONT releases Remora:most comprehensive methylation
Regulatory Filings
2022-05-26 English
Oxford Nanopore announces tech updates
Environmental & Social Information
2022-05-20 English
ONT opens user conference, rich science programme
Regulatory Filings
2022-05-19 English
ONT chosen for comprehensive human genome program
Regulatory Filings
2022-05-13 English
Share Incentive Plan - Director/PDMR Shareholding
Remuneration Information
2022-05-11 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-05-03 English
Group of companies' accounts made up to 2021-12-31
Regulatory Filings
2022-04-29 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-04-12 English
2021 Annual Report
Annual Report FY 2021
2022-04-12 English
Proxy Form
AGM Information
2022-04-12 English
Notice of AGM
AGM Information
2022-04-12 English
Director/PDMR Shareholding
Remuneration Information
2022-04-12 English
Director/PDMR Shareholding
Director's Dealing
2022-04-12 English
Publication of Annual Report and Notice of AGM
Report Publication Announcement
2022-04-12 English
Block listing Interim Review
Regulatory Filings
2022-04-06 English
Director/PDMR Shareholding
Director's Dealing
2022-04-05 English
Genomics England expands Nanopore use in cancer
Regulatory Filings
2022-04-04 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-04-01 English
Agreement
Regulatory Filings
2022-04-01 English
ONT shows new high-accuracy, high-output chemistry
Regulatory Filings
2022-03-30 English
Nanopore sequencing profiles TB: FIND evaluation
Environmental & Social Information
2022-03-24 English
Oxford Nanopore releases Short Fragment Mode
Environmental & Social Information
2022-03-23 English
Preliminary Results and Guidance Update
Earnings Release FY 2021
2022-03-22 English
Share Incentive Plan - Director/PDMR Shareholding
Remuneration Information
2022-03-11 English
Holding(s) in Company
Major Shareholding Notification
2022-03-10 English
Publication: Nanopore IDs >50 genetic diseases
Regulatory Filings
2022-03-08 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-03-01 English
Notice of Results
Report Publication Announcement
2022-02-24 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing
2022-02-11 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2022-02-01 English
Appointment of Senior Independent Director
Board/Management Information
2022-01-24 English
Holding(s) in Company
Major Shareholding Notification
2022-01-18 English
Fastest human genome sequence uses Oxford Nanopore
Regulatory Filings
2022-01-13 English
Share Incentive Plan - Director/PDMR Shareholding
Share Issue/Capital Change
2022-01-11 English
Update to FY21 revenue guidance
Earnings Release FY 2021
2022-01-07 English
Company to present at JP Morgan Healthcare conf
Regulatory Filings
2022-01-07 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2022-01-04 English